AA
CERE

AlphaCentric Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

AlphaCentric Advisors’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42,500
Closed -$1.74M – 243
2024
Q2 		$1.74M Hold
42,500
– – 1.28% 20
2024
Q1 		$1.8M Buy
42,500
+17,500
+70% +$740K 1.08% 29
2023
Q4 		$1.06M Buy
+25,000
New +$1.06M 0.71% 54